{"id":119992,"date":"2021-04-07T01:36:48","date_gmt":"2021-04-07T01:36:48","guid":{"rendered":"https:\/\/precoinnews.com\/?p=119992"},"modified":"2021-04-07T01:36:48","modified_gmt":"2021-04-07T01:36:48","slug":"making-strides-in-covid-19-battle","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/business\/making-strides-in-covid-19-battle\/","title":{"rendered":"Making Strides in Covid-19 battle"},"content":{"rendered":"

Unlike its giant outsourcing companies such as Tata Consultancy Services and Infosys Technologies, India’s pharmaceutical makers are a lot less understated in their public profiles even as they are the No. 1 supplier of generics globally.<\/p>\n

Those who know something of the industry would recognise Sun Pharma, Cipla and Dr Reddy’s Laboratories as among the better known names in a highly fragmented space. In the first quarter of this year, one firm that caught global attention was Bangalore-based Strides Pharma Science.<\/p>\n

Please subscribe or log in to continue reading the full article.<\/p>\n

Get unlimited access to all stories at $0.99\/month<\/h4>\n